RPG Life Sciences
RPGLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Harsh Goenka · MD: Yugal Sikri · Listing date: June 11, 2008 · Employees: 1107 · Mumbai · http://www.rpglifesciences.com

Stock Price vs Company Growth
1d
2.1%
1w
8.4%
1m
9.8%
3m
15.1%
6m
1.8%
1y
84.6%
5y
46.2%
10y
37.3%
all
26.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,423 2.1%
1,364
1,740
Company Overview

Sales
582 Cr
Growth: 14.7%
Profit after Tax
87.7 Cr
Growth: 3.4%
Small Cap
2,353 Cr
P/E: 26.9x
Industry P/E: 34.4x
Fundamentals

Sales (Cr) ₹ 582
Growth 14.7%
EBITDA 22.0%
P/S 4.1x
Dividend 1.2%
P/E 26.9x
Book Value ₹ 227
PEG Ratio 1.8x
ROE 24.3%
P/B 6.3x
Shareholding Pattern

Institutions
Promoters
Nucleus Life Trust (Mr. Harsh Vardhan Goenka Is A Trustee)
53.42 %
Ektara Enterprises Llp
15.2 %
Stel Holdings Limited
3.18 %
Harsh Vardhan Goenka
0.16 %
Mala Goenka
0.05 %
Others
Authum Investment And Infrastructure Limited
1.98 %
Iepf
0.86 %
Llp
0.02 %
Increase    Decrease    No change
Company Profile Detailed

RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company’s name was changed to RPG Life Sciences Ltd effective April 1, 1999.
Investors (58)
Followers (4)